- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Thyrocare's promoter entity, Docon Technologies, has sold 1,57,69,696 equity shares, representing 9.9% of the company's total paid-up capital. This open market disposal reduces the promoter's overall shareholding from 60.92% to 51.02%. Docon Technologies will continue as a promoter for Thyrocare.